U.S. Physical Therapy, Inc. (NYSE:USPH – Get Free Report) announced a quarterly dividend on Wednesday, November 6th, Wall Street Journal reports. Stockholders of record on Friday, November 15th will be paid a dividend of 0.44 per share on Friday, December 6th. This represents a $1.76 dividend on an annualized basis and a dividend yield of 1.81%. The ex-dividend date is Friday, November 15th.
U.S. Physical Therapy has raised its dividend payment by an average of 75.2% annually over the last three years. U.S. Physical Therapy has a dividend payout ratio of 60.1% indicating that its dividend is sufficiently covered by earnings. Equities analysts expect U.S. Physical Therapy to earn $2.95 per share next year, which means the company should continue to be able to cover its $1.76 annual dividend with an expected future payout ratio of 59.7%.
U.S. Physical Therapy Trading Up 17.7 %
NYSE USPH traded up $14.57 during trading hours on Wednesday, reaching $97.10. The company’s stock had a trading volume of 267,762 shares, compared to its average volume of 91,244. The firm has a fifty day simple moving average of $82.93 and a 200-day simple moving average of $91.49. The company has a debt-to-equity ratio of 0.28, a current ratio of 1.88 and a quick ratio of 1.88. U.S. Physical Therapy has a 52 week low of $76.18 and a 52 week high of $113.63. The stock has a market cap of $1.46 billion, a P/E ratio of 77.83, a P/E/G ratio of 3.93 and a beta of 1.38.
Insider Buying and Selling at U.S. Physical Therapy
In related news, Director Kathleen A. Gilmartin acquired 2,000 shares of the business’s stock in a transaction dated Tuesday, September 3rd. The shares were bought at an average price of $86.09 per share, with a total value of $172,180.00. Following the transaction, the director now directly owns 18,904 shares of the company’s stock, valued at $1,627,445.36. This trade represents a 0.00 % increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. In related news, COO Graham D. Reeve sold 1,724 shares of U.S. Physical Therapy stock in a transaction on Wednesday, August 21st. The shares were sold at an average price of $82.50, for a total value of $142,230.00. Following the completion of the sale, the chief operating officer now owns 7,038 shares of the company’s stock, valued at approximately $580,635. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Kathleen A. Gilmartin acquired 2,000 shares of the stock in a transaction on Tuesday, September 3rd. The shares were acquired at an average price of $86.09 per share, for a total transaction of $172,180.00. Following the acquisition, the director now owns 18,904 shares of the company’s stock, valued at approximately $1,627,445.36. The trade was a 0.00 % increase in their position. The disclosure for this purchase can be found here. Insiders own 1.70% of the company’s stock.
Analyst Ratings Changes
USPH has been the subject of a number of analyst reports. Bank of America reissued a “neutral” rating and set a $90.00 target price (down previously from $114.00) on shares of U.S. Physical Therapy in a research note on Monday, October 7th. Barrington Research reissued an “outperform” rating and issued a $108.00 price objective on shares of U.S. Physical Therapy in a research note on Wednesday, October 9th. Finally, StockNews.com raised U.S. Physical Therapy from a “sell” rating to a “hold” rating in a research note on Wednesday, August 21st.
View Our Latest Research Report on U.S. Physical Therapy
About U.S. Physical Therapy
U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.
Read More
- Five stocks we like better than U.S. Physical Therapy
- How is Compound Interest Calculated?
- What a Trump Win Looks Like for the Market Now and Into 2025
- TSX Venture Exchange (Formerly Canadian Venture Exchange)
- Russell 2000 Surge Post-Election: How to Play the Small-Cap Pop
- What is the Euro STOXX 50 Index?
- Macro Headwinds Send Microchip Technology Stock to the Buy Zone
Receive News & Ratings for U.S. Physical Therapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy and related companies with MarketBeat.com's FREE daily email newsletter.